BCRX Recent News BioCryst Presents BCX4161 Phase

BCRX Recent News

BioCryst Presents BCX4161 Phase 1 Trial and Kallikrein Inhibition Assay Results GlobeNewswire - Sat Mar 01, 10:58AM CST
Avanir Pharmaceuticals (AVNR) Jumps: Stock Moves 11.7% Higher - Tale of the Tape Zacks Investment Research - Thu Feb 27, 8:46AM CST
BioCryst Pharmaceuticals Q4 Loss Shrinks 51% on Higher Collaborative Revenue Motley Fool - Wed Feb 26, 11:17AM CST
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Rises 10.5% - Tale of the Tape Zacks Investment Research - Wed Feb 26, 8:39AM CST
Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session - Tale of the Tape Zacks Investment Research - Wed Feb 26, 7:51AM CST
BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results GlobeNewswire - Wed Feb 26, 5:51AM CST
Why BioCryst Pharmaceuticals, Inc. Shares Spiked Higher Motley Fool - Tue Feb 25, 1:52PM CST
Today's Biggest Biotech Stories: BioCryst, Verastem, and InterMune Motley Fool - Tue Feb 25, 8:35AM CST
RXi Pharmaceuticals (RXII) Jumps: Stock Adds 28.5% in Session - Tale of the Tape Zacks Investment Research - Tue Feb 25, 7:51AM CST
BioCryst Announces Peramivir NDA Acceptance by the FDA GlobeNewswire - Tue Feb 25, 5:45AM CST